AMPK–SQSTM1 Feedback Loop Orchestrates Tumor Antioxidant Defense

Study Background and Research Question

The tumor microenvironment is characterized by persistent metabolic and oxidative stresses, arising from nutrient depletion and elevated reactive oxygen species (ROS) levels. Tumor cells must adapt to these hostile conditions to survive and proliferate. The STK11/LKB1–AMPK pathway is a central regulator of cellular energy homeostasis, activated during metabolic stress to maintain ATP and NADPH levels. In parallel, the KEAP1–NFE2L2/NRF2 axis is a key antioxidant defense mechanism. Notably, co-occurring mutations in KEAP1 and STK11/LKB1 are frequently observed in non-small cell lung cancer (NSCLC), yet the molecular rationale for their coexistence and the crosstalk between their associated pathways under metabolic stress remain poorly understood. The central research question addressed by this study is how metabolic stress coordinates AMPK and NFE2L2/NRF2 activation through molecular feedback to enhance tumor antioxidant capacity.

Key Innovation from the Reference Study

The principal innovation of this work is the elucidation of a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress. This loop mediates the dual activation of AMPK and NFE2L2/NRF2, synergistically enhancing the antioxidant defense system of tumor cells. Critically, the study identifies that metabolic stress increases both expression and phosphorylation of SQSTM1/p62, which in turn facilitates macroautophagic degradation of KEAP1 (a negative regulator of NFE2L2/NRF2) and promotes assembly of the AXIN–STK11–AMPK complex at the lysosomal membrane. Therefore, SQSTM1/p62 acts as a pivotal integrator of metabolic and oxidative stress responses, providing mechanistic insight into why STK11 and KEAP1 mutations may co-occur in lung cancer evolution.

Methods and Experimental Design Insights

The authors employed a combination of genetic, biochemical, and cell biological approaches to dissect the feedback interactions between AMPK and SQSTM1/p62. Key experimental systems included mouse embryonic fibroblasts (MEFs) and human NSCLC cell lines with defined genetic backgrounds (e.g., STK11/LKB1 and KEAP1 status). Metabolic stress was induced by glucose deprivation or treatment with metabolic inhibitors. Autophagic activity and protein-protein interactions were assessed using immunoprecipitation, immunoblotting, and fluorescent microscopy with relevant markers and reporters. The functional consequences of SQSTM1/p62 expression and phosphorylation were interrogated via site-directed mutagenesis, with attention to S24 and S226 residues. Downstream antioxidant responses were measured by quantifying NFE2L2/NRF2 target gene expression and cellular redox status. Pharmacological modulation of lysosomal function (e.g., with bafilomycin A1 or concanamycin A) and signaling intermediates (e.g., MAP3K7/TAK1, PP2A) further clarified pathway dependencies.

Protocol Parameters

• Metabolic stress induction: Glucose deprivation in culture media for 12–24 hours to simulate tumor-like nutrient-deficient environments.
• AMPK activation assessment: Immunoblot for phosphorylated AMPK (Thr172) and quantification of NADPH/ATP levels post-stress.
• SQSTM1/p62 phosphorylation analysis: Western blot with phosphorylation-specific antibodies; S24A/S226A mutants to dissect functional impact.
• NFE2L2/NRF2 activation readout: RT-qPCR for downstream antioxidant response genes (e.g., NQO1, HO-1) and subcellular NRF2 localization by immunofluorescence.
• KEAP1 autophagic degradation: Lysosomal inhibitors (e.g., bafilomycin A1) to confirm dependency on autophagy for KEAP1 turnover.
• ROS measurement: DCFDA or equivalent fluorescent probes post-stress and intervention.
• Lysosomal pH modulation: Use of lactic acid to manipulate intracellular proton levels and assess impact on feedback loop integrity.

Core Findings and Why They Matter

The study demonstrates that metabolic stress drives upregulation and phosphorylation of SQSTM1/p62, which is essential for the dual activation of AMPK and NFE2L2/NRF2. Mechanistically, SQSTM1/p62 promotes autophagic degradation of KEAP1, thereby releasing inhibition of NFE2L2/NRF2, and simultaneously facilitates assembly of the AXIN–STK11–AMPK complex on lysosomal membranes. Importantly, AMPK activity is in turn necessary for maintaining SQSTM1/p62 expression and phosphorylation—a double-positive feedback arrangement. This synergy is further regulated by lysosomal deacidification, impacting transcription factor activity (TFEB, TFE3) and MAP3K7/TAK1-dependent phosphorylation. The work pinpoints SQSTM1 phosphorylation at S24 and S226 as crucial for pathway activation. Notably, the feedback loop's activity is sensitive to changes in lysosomal pH, as provision of lactic acid-derived protons can abrogate the metabolic stress response.

These findings clarify how tumors with co-occurring STK11 and KEAP1 mutations can coordinate metabolic and antioxidant responses to adapt and thrive in hostile microenvironments, offering a compelling rationale for the frequent co-selection of these mutations in NSCLC. This mechanistic insight advances our understanding of tumor metabolic adaptation and identifies potential points of therapeutic intervention targeting feedback circuitry.

Comparison with Existing Internal Articles

Several internal articles, such as "AMPK–SQSTM1 Double-Positive Feedback Enhances Tumor Antioxidant Defense" and "AMPK–SQSTM1 Feedback Loop Synergizes Antioxidant Defense in Tumors", have highlighted the emerging importance of AMPK–SQSTM1/p62 crosstalk in cancer cell stress adaptation. These resources summarize key aspects of the feedback mechanism and its implications for the metabolic resilience of NSCLC. The present study builds on these insights by providing detailed mechanistic data on the phosphorylation events and the role of lysosomal pH, adding significant depth to the understanding of how metabolic and oxidative stress responses are co-regulated in cancer cells.

For researchers interested in the interface of pain signaling and metabolic adaptation, complementary articles such as "AMG 9810: Advanced TRPV1 Antagonist Workflows & Troubleshooting" discuss the utility of TRPV1 antagonists in dissecting sensory neuron signaling under metabolic stress, offering protocol insights that may inform related experimental setups.

Limitations and Transferability

While the study offers robust mechanistic insight, its primary findings are derived from in vitro cell-based systems and selected murine models. The relevance of the AMPK–SQSTM1–NFE2L2 feedback loop to other tumor types or non-cancerous tissues under metabolic stress remains to be established. Furthermore, the precise contribution of S24 and S226 phosphorylation events may vary depending on cell context and upstream signaling landscape. The interplay between lactic acid metabolism and lysosomal pH warrants further exploration in physiologically relevant in vivo tumor models. Therefore, while the feedback loop is a promising target for intervention, translation to clinical settings will require additional validation.

Research Support Resources

To facilitate research on sensory neuron signaling and metabolic stress, investigators can employ specific pharmacological tools. For instance, AMG 9810 (SKU B7018) is a potent and selective TRPV1 antagonist that supports inhibition of capsaicin-induced calcium influx and CGRP release inhibition assays, key readouts in pain mechanism research. AMG 9810’s high solubility in DMSO and nanomolar potency make it suitable for sensory neuron signaling studies and protocols requiring precise modulation of TRPV1 activity, as detailed in the internal workflow guide. Researchers are advised to follow recommended storage and handling procedures to maintain compound integrity.